Activation of TLR4 promotes oxidative inflammation via NADPH oxidase signaling in platelets of subjects with autism spectrum disorder.
4 affiliations
- 1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. [email protected].
- 2Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- 3Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- 4Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. [email protected].
Abstract
Autism spectrum disorder (ASD) is a complex neurobehavioral disorder where both immune system and neurological dysregulations are known to play crucial roles. Platelets are known to play key roles in systemic oxidative inflammation through production of oxidants. However, there is still scarcity of data regarding the role of blood platelets in ASD subjects. Platelets are known to express innate receptors such as toll-like receptor 4 (TLR4), transcription factors such as NFkB, and oxidative enzymes such as NADPH oxidase (NOX2), however the molecular mechanisms in generation of oxidative inflammation in platelets of ASD subjects have not been investigated until now. Therefore, this study was aimed at investigating expression of TLR4, NFkB, NOX2, reactive oxygen species (ROS) and lipid peroxides (a marker of oxidative damage on lipid membranes) in platelets of ASD children (n = 27) and typically developing children (TDC; n = 22) through molecular and biochemical analyses. Further, correlation analysis was carried out with severity of the disease. Our data showed an upregulated expression of TLR4 and p-NFkB in ASD platelets as compared to TDC platelets. Further, elevated TLR4/ NFkB signaling was linked with elevated NOX2-derived ROS and oxidative stress. It was confirmed by the utilization of NFkB and NOX2 inhibitors which caused reduction in LPS-induced ROS and oxidative stress in ASD platelets. Further, there was positive correlation between platelet oxidative stress and severity of the disease. Our data suggests that elevated TLR4/ NFkB signaling in platelets of ASD subjects might predispose them to increased systemic oxidative inflammation through NOX-2 derived ROS generation and oxidative stress.
Related
- Early Insulin Signaling Defects and Oxidative Stress Kinase Activation Precede Tau Pathology in PS19 Tau Transgenic Mice
- Acute respiratory distress syndrome FXR/Sptlc2 signaling promotes alveolar macrophage mitophagy and limits lung inflammation
- Transient activation of ciliary CCR2 signaling promotes the initiation of adipogenesis.
- HMGN5 promotes renal tubular inflammation and pyroptosis-associated signaling in chronic kidney disease via the IFNAR2 axis
- The E3 ubiquitin ligase HECTD3 controls immune colonic inflammation by restricting MyD88 activation and signaling
BibTeX
@article{algahtani2026activation,
title = {{Activation of TLR4 promotes oxidative inflammation via NADPH oxidase signaling in platelets of subjects with autism spectrum disorder.}},
author = {Mohammad M Algahtani and Sheikh F Ahmad and Naif O Al-Harbi and Laila Y Al-Ayadhi and Khalid Alhazzani and Sabry M Attia and Ahmed Z Alanazi and Saleh A Bakheet and Ahmed Nadeem},
journal = {Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society},
year = {2026},
month = oct,
doi = {10.1007/s44446-026-00115-w},
url = {https://europepmc.org/article/MED/42907733},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Activation of TLR4 promotes oxidative inflammation via NADPH oxidase signaling in platelets of subjects with autism spectrum disorder.
AU - Mohammad M Algahtani
AU - Sheikh F Ahmad
AU - Naif O Al-Harbi
AU - Laila Y Al-Ayadhi
AU - Khalid Alhazzani
AU - Sabry M Attia
AU - Ahmed Z Alanazi
AU - Saleh A Bakheet
AU - Ahmed Nadeem
PY - 2026
DA - 2026/10/21
JO - Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
DO - 10.1007/s44446-026-00115-w
UR - https://europepmc.org/article/MED/42907733
AB - Autism spectrum disorder (ASD) is a complex neurobehavioral disorder where both immune system and neurological dysregulations are known to play crucial roles. Platelets are known to play key roles in systemic oxidative inflammation through production of oxidants. However, there is still scarcity of data regarding the role of blood platelets in ASD subjects. Platelets are known to express innate receptors such as toll-like receptor 4 (TLR4), transcription factors such as NFkB, and oxidative enzymes such as NADPH oxidase (NOX2), however the molecular mechanisms in generation of oxidative inflammation in platelets of ASD subjects have not been investigated until now. Therefore, this study was aimed at investigating expression of TLR4, NFkB, NOX2, reactive oxygen species (ROS) and lipid peroxides (a marker of oxidative damage on lipid membranes) in platelets of ASD children (n = 27) and typically developing children (TDC; n = 22) through molecular and biochemical analyses. Further, correlation analysis was carried out with severity of the disease. Our data showed an upregulated expression of TLR4 and p-NFkB in ASD platelets as compared to TDC platelets. Further, elevated TLR4/ NFkB signaling was linked with elevated NOX2-derived ROS and oxidative stress. It was confirmed by the utilization of NFkB and NOX2 inhibitors which caused reduction in LPS-induced ROS and oxidative stress in ASD platelets. Further, there was positive correlation between platelet oxidative stress and severity of the disease. Our data suggests that elevated TLR4/ NFkB signaling in platelets of ASD subjects might predispose them to increased systemic oxidative inflammation through NOX-2 derived ROS generation and oxidative stress.
SN - 1319-0164
SN - 2213-7475
ER -